Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

NEW HAVEN, Conn., Aug. 15 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that it had accrued a total of 85 patients to the pivotal Phase II trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in previously untreated elderly patients with de novo poor-risk acute myelogenous leukemia (AML).

Alan Kessman, Chief Executive Officer said, "We are extremely pleased to have reached this milestone in the pivotal Phase II trial of our lead anticancer agent. We will now proceed to analyze the data and, if warranted, prepare a New Drug Application for submission to the U.S. Food and Drug Administration in 2008." He added, "We continue to plan on the release of preliminary data from this trial at the American Society of Hematology (ASH) Meeting in December."

The pivotal Phase II trial, initiated in May 2006, is evaluating Cloretazine(R) (VNP40101M) as a single agent in previously untreated AML patients over the age of 60 with de novo poor-risk AML. Patients are eligible for this trial if they are at least 60 years of age with de novo AML and have one of the following additional risk factors: (i) unfavorable cytogenetics; (ii) an ECOG performance status of 2 or greater; or (iii) a co-morbid condition that precludes them from receiving cytotoxic therapy with cytarabine and an anthracycline. Patients over the age of 70 with de novo AML who do not have favorable cytogenetics are also eligible.

The primary endpoint for this trial is the complete response rate (including complete remission (CR) and complete remission with incomplete platelet recovery (CRp)). Secondary endpoints include overall survival, disease-free survival and progression-free survival.

The trial ha
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... LONDON , BERLIN and ... The global market has the potential to grow to ... leading provider of market research reports has announced pharma industry ... Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable ... in terms of US pricing structures and the anticipated approval ...
(Date:9/15/2014)... GENEVE , September 15, 2014 /PRNewswire/ ... des principaux fabricants européens de sortir ou ... marché ou au soutien réglementaire de la ... alcaloïdes tropaniques comme principes pharmaceutiques actifs (API), ... la nortropine, le méthylbromure d,homatropine, le bromhydrate d,homatropine, ...
(Date:9/14/2014)... DIEGO , Sept. 14, 2014 HUYA ... global development of China,s pharmaceutical ... Institute of Pharmaceutical Research (TIPR) to develop medical ... and the western world, for global markets. ... venture, to be known as TIPR-HUYA Advancing Innovative Medicines ...
Breaking Medicine Technology:Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 2Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 3Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 2Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 2HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 4
... (Nasdaq: ARAY ), the premier radiation ... Especialidad in Monterrey, Mexico has starting treating patients with ... is the first center in Mexico now offering patients ... anywhere in the body. The CyberKnife System ...
... Jan. 17, 2012  Ventana Medical Systems, Inc. (Ventana), ... that it has entered into a strategic collaboration ... a molecular companion diagnostic test intended to identify ... Bayer antibody-drug conjugate (ADC). Ventana,s diagnostic immunohistochemistry platform ...
Cached Medicine Technology:First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 2First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 3First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 4Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 2Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 3
(Date:9/15/2014)... 15, 2014 The New York Times(1) ... Liberia that is fast becoming a worldwide threat. In ... answer the World Health Organization’s (WHO) immediate call for ... novel set of experimental frequencies that may be useful ... Ebola Zaire infection. , The World Health Organization(2) stated, ...
(Date:9/15/2014)... September 15, 2014 Stem cells are ... and can divide (through mitosis) to produce more stem ... of cardiovascular diseases, leukemia (a kind of hematological system ... kidney and other parenchymal organs, etc. , Currently, cord ... amid stem cell upstream sectors and even the whole ...
(Date:9/15/2014)... BRITISH COLUMBIA (PRWEB) September 15, 2014 ... will be presenting a poster, Utilization of Psychological ... the September 2014 Canadian Fertility and Andrology Annual Meeting ... Olive team: Dr Jason Hitkari; Kelly Gray RN, MSN; ... , While the jury is still out on whether ...
(Date:9/15/2014)... 15, 2014 In addition to hosting, ... evaluations and spinal assessments. Chair massages will be offered ... Grigo will be serving homemade jams and muffins. ... facials, Nancy Duensing will teach about doTERRA Essential Oils ... kids will enjoy activities from face-painting to a coloring ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Hawkins Parnell Thackston ... has relocated to 600 Lexington Avenue at 52nd Street. HPTY ... in this premier office building, a block away from the ... Lexington. , According to John Canoni, partner-in-charge of the New ... serve our clients, and is convenient to mass transit for ...
Breaking Medicine News(10 mins):Health News:World Health Organization OKs Efforts to Research “Unproven Interventions” -- Sound Health Research Responds 2Health News:World Health Organization OKs Efforts to Research “Unproven Interventions” -- Sound Health Research Responds 3Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Utilization of Psychological Counselling During IVF: Implications for Nursing Practice 2Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 2Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 3
... MD, former chief of pediatrics at Women & Infants Hospital ... Brown University, was recently inducted into the Legends of Neonatology ... Oh was one of two physicians inducted this year for ... Later this month, Dr. Oh will also receive another prestigious ...
... Baltimore, MD A study released today by the ... Bloomberg School of Public Health has identified the most ... could offer the best hope yet for scaling up ... taking aim at the country,s precipitous number of child ...
... 12 (HealthDay News) -- A toxic component of a plant ... failure and upper urinary tract cancer, researchers warn. Aristolochic ... used for centuries and still are used in many countries. ... cancer in Taiwan concluded that aristolochic acid is a primary ...
... THURSDAY, April 12 (HealthDay News) -- Even though a child,s ... finds that the marriages and partnerships of parents of kids ... study debunks "a persistent myth that childhood cancer will have ... simply not true," said Anne Kazak, professor of pediatrics at ...
... , WEDNESDAY, April 11 (HealthDay News) -- The U.S. ... producers, drug companies and veterinarians to help limit the ... of mixing antibiotics in animal feed to make livestock, ... to disease has been criticized for years in many ...
... A first of its kind study conducted by ... (IPC) found that one fall requiring first responder emergency ... hours at Boston Logan International Airport, with 37 percent ... study, which was done at the request of the ...
Cached Medicine News:Health News:Dr. William Oh named 2012 Legend of Neonatology 2Health News:New study identifies promising, achievable solutions to Nigeria's childhood mortality crisis 2Health News:New study identifies promising, achievable solutions to Nigeria's childhood mortality crisis 3Health News:Herbal Remedy Ingredient Tied to Cancer, Kidney Failure 2Health News:Parents of Kids With Cancer No More Likely to Break Up 2Health News:FDA Seeks to Limit Antibiotics in Animal Feed 2Health News:FDA Seeks to Limit Antibiotics in Animal Feed 3Health News:BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport 2
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
... Manage and Retrieve a ... DVMR- office, the first digital ... the physician's office environment. DVMR ... of high-resolution cameras for simple ...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: